Home2024-07-11T14:44:14+00:00
Loading...

About the MC2 Center

The Multi-Consortia Coordinating (MC2) Center supports six NCI Division of Cancer Biology (DCB) funded programs which are made up of interdisciplinary communities of scientists. These scientists are working to integrate approaches, data, and tools to address important questions in basic and translational cancer research.The overarching goals of the MC2 Center are to a) use an evidence-based infrastructure to catalyze collaboration and promote a diverse and inclusive research community, b) improve interoperability and usability of DCB program data and tools, and c) support the growth of a strong, stable and diverse cancer research community beyond DCB programs.

The MC2 Center is made up of three hubs: the Collaboration Hub, the Resource Coordination Hub, and the Outreach Hub. These hubs are managed by Sage Bionetworks Scientific Community Managers, Project Managers, Scientists and Data Engineers. We also work in partnership with external collaborators at Harvard, Yale, Columbia, Wisconsin and UC Anschutz. Through these hubs we support each center or project’s professional cancer researchers, early career researchers, patient advocates, and program directors. 

With the MC2 Center community spread out across the country, most collaborative work takes place virtually. The community participates through online steering committees, working groups, special interest groups and in conversation through our slack workspaces. We also hold in-person Annual Investigator meetings, open to all participating members of the MC2 Center, for each program, as well as ideation jams, hackathons, seminar series, and more. Participation in the MC2 Center, as well as publications, tools and data are shared through the Cancer Complexity Knowledge Portal.

The MC2 Center is funded thanks to a five-year U24 grant from the NIH/NCI Division of Cancer Biology (U24CA274494).

Latest News

Publication Highlight: Combined KRAS-MAPK pathway inhibitors and HER2-directed drug conjugate is efficacious in pancreatic cancer

April 12, 2024|Categories: Community News, Investigator Highlight, News|

Guest Author: Ashenafi Bulle, Ph.D., Washington University School of Medicine in St. Louis In this work, we shed light on the significance of drug combinations [...]

Virtual Workshop – Spatial Multi-Omics for Cancer Systems Biology

January 2, 2024|Categories: Community News, Event|Tags: , , , |

ISB in collaboration with the NCI Cancer Systems Biology Consortium and MC2 Centers is hosting a free virtual workshop, "Spatial Multi-Omics for Cancer Systems Biology," [...]

Go to Top